NYSE · USD
Shoulder Innovations, Inc. (SI) Stock Analysis
Shoulder Innovations, Inc. (SI) is a stock listed on NYSE and quoted in US Dollar.
Last Updated: October 22, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
SI Key Statistics
As of Oct 22, 2026Trading
- Open
- $19.34
- Previous Close
- $19.34
- Day's Range
- 19.47–19.94
- 52-Week Range
- 10.92–24.60
- Volume
- 57.97K
Valuation
- Market Cap
- $411.17M
- P/E Ratio
- 24.38
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 0.81
Financials (FY)
- Revenue (FY)
- $47.32M+49.63%
- Net Income (FY)
- −$40.36M
- Shares Outstanding
- 20.82M
- 1-Year Return
- +53.82%
Dividend and dates
- Earnings Date
- November 5, 2026
- Avg Volume
- 116.37K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 22, 2026, SI closed at $19.75, +53.82% over 1 year.
Shoulder Innovations, Inc. (SI) has a market capitalization of $411.17M.
In fiscal 2025, SI reported revenue of $47.32M.
SI Stock Return by Calendar Year
Shoulder Innovations, Inc. (SI) return since Jul 2025: what $10,000 became
- 1 year
- $10,000 $15,382
- +53.82%
- Since Jul 2025
- $10,000 $13,123
- +31.23%
If you had invested $10,000 in Shoulder Innovations, Inc. (SI) at the close on July 31, 2025, the earliest close on record here, it would have been worth $13,123 at the close on October 22, 2026: +31.23% in total, +24.80% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +38.11% |
| 2025 (partial year) | −4.98% |
As of October 22, 2026.
SI Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $47.32M | −$40.36M | −85.3% |
| 2024 | $31.62M | −$15.62M | −49.4% |
| 2023 | $19.27M | −$12.66M | −65.7% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $47.32M | $36.20M | −$26.30M | −$40.36M | −85.3% |
| 2024 | $31.62M | $24.34M | −$14.65M | −$15.62M | −49.4% |
| 2023 | $19.27M | $15.27M | −$10.86M | −$12.66M | −65.7% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
Recent News
Shoulder Innovations to Report Third Quarter 2026 Financial Results on November 5, 2026
YahooTranscript: Shoulder Innovations Q2 2026 Earnings Conference Call
BenzingaBTIG Maintains Buy on Shoulder Innovations, Raises Price Target to $27
BenzingaShoulder Innovations, Inc. (SI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
SeekingAlphaShoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch
YahooShoulder Innovations Receives FDA Clearance For Its N-22 Humeral Head
Benzinga
All 20 articles ↓Show fewer ↑
Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures
YahooShoulder Innovations Enters Into Exclusive Collaboration With ALM Ortho For Bespoke Shoulder Implant; Financial Terms Remain Confidential
BenzingaShoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience
YahooShoulder Innovations Enters Into A Settlement Agreement With Catalyst Orthoscience To Resolve All Outstanding Patent Litigation Between The Two Companies
BenzingaShoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference
YahooShoulder Innovations (SI) Price Target Increased by 14.13% to 26.78
FintelUBS Maintains Buy on Shoulder Innovations, Raises Price Target to $28
BenzingaShoulder Innovations Files $300M Mixed Securities Shelf Prospectus And Registers Resale Of 8,103,026 Common Shares By Selling Stockholders
BenzingaPiper Sandler Reiterates Overweight on Shoulder Innovations, Raises Price Target to $25
BenzingaBTIG Maintains Buy on Shoulder Innovations, Raises Price Target to $26
BenzingaShoulder Innovations (NYSE:SI) Posts In-Line Q2 Results, Raises Full-Year Outlook
ChartMillShoulder Innovations, Inc. (SI) Q2 2026 Earnings Call Transcript
SeekingAlphaShoulder Innovations Q2 EPS $(0.49) Misses $(0.46) Estimate, Sales $17.175M Beat $16.573M Estimate
BenzingaShoulder Innovations Raises FY2026 Sales Guidance from $65.000M-$68.000M to $67.000M-$69.000M vs $67.283M Est
Benzinga
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 22, 2026.













